Robot model
Garmin (Venu / Fenix / Forerunner)
Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.
Garmin (Venu / Fenix / Forerunner) is a biometric robot built by
Machine-readable surfaces
- Markdown mirror: /models/garmin-watch.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/8c2ce210-43fe-4687-95ea-ee7f63ee9a06
- Data documentation: /data
- Form factor
- biometric
- Maturity stage
- commercial
- Lifecycle
- active
- Deployments
- 0
- ID
8c2ce210-43fe-4687-95ea-ee7f63ee9a06
Specs
- notes
- [object Object],[object Object],[object Object],[object Object]
- specs
- Venu 3, Fenix 8, Forerunner 965 (+ epix Pro, tactix). Sensors: Elevate optical HR, Pulse Ox (SpO2), ECG (select models), skin temp. AI/health: Body Battery (energy/recovery proxy), Training Load / Training Readiness / recovery-time, advanced sleep + Sleep Score + sleep coach, all-day stress (HRV), HRV Status, Morning Report. Founded 1989 (NASDAQ: GRMN). PURCHASE-ONLY; optional Garmin Connect+ AI subscription ($6.99/mo, Mar 2025) does NOT gate existing features.
- formFactor
- biometric (biometric-primary multisport watch + AI augmentation; ECG cleared, rest wellness)
Supply chain
No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this model’s suppliers.
Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.
Sources (3)
Common questions
- What is Garmin (Venu / Fenix / Forerunner)?
- Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.
- Who makes Garmin (Venu / Fenix / Forerunner)?
- Garmin (Venu / Fenix / Forerunner) is made by Garmin, based in Olathe, Kansas, USA, founded in 1989.
- Where is Garmin (Venu / Fenix / Forerunner) deployed?
- No verified deployments of Garmin (Venu / Fenix / Forerunner) are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- What is Garmin (Venu / Fenix / Forerunner)'s maturity stage?
- Garmin (Venu / Fenix / Forerunner) is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.